Antileukemic Agent

Any substance that treats, prevents, or inhibits the development of leukemia.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
In BCR-ABL-positive chronic myeloid leu-kemia (CML), the tyrosine kinase inhibitor (TKI) imatinib acts as an antileukemic agent… (More)
  • table 1
Is this relevant?
2004
2004
Arsenic trioxide (As(2)O(3)) caused apoptosis in U-937 human promonocytic cells. This effect was potentiated by the simultaneous… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Glucosinolates (GL) can inhibit, retard or reverse experimental multistage carcinogenesis. When brassica plant tissue is broken… (More)
  • figure 1
  • figure 2
  • table II
  • figure 3
Is this relevant?
2002
2002
PURPOSE The purpose of the study is to investigate the tolerability of interleukin 2 (IL-2) after intensive chemotherapy in… (More)
  • figure 1
  • table 1
  • table 2
  • figure 3
  • figure 2
Is this relevant?
2000
2000
The nucleoside analogue cordycepin (3'-deoxyadenosine, 3'-dA) is substantially more cytotoxic to terminal deoxynucleotidyl… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
The PML protein, identified first as part of the oncogenic PML-RARalpha chimera in acute promyelocytic leukemia (APL… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 7
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Cancer is a disease characterized by defects in growth control, and tumor cells often display abnormal patterns of cellular… (More)
Is this relevant?
1989
1989
1,7-Heptanediol disulfamate (hepsulfam, NSC 329680) is a new antileukemic agent with close structural similarity to busulfan. The… (More)
  • figure 4
  • figure 5
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
1983
Highly Cited
1983
2-Chlorodeoxyadenosine (CdA), an adenosine-deaminase-resistant purine deoxynucleoside, is markedly toxic toward human T… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?